MyHealthchecked (MHC)

Sector:

Health Care

Index:

FTSE AIM All-Share

4.20p
   
  • Change Today:
    -0.25p
  • 52 Week High: 6.70
  • 52 Week Low: 0.80
  • Currency: UK Pounds
  • Shares Issued: 725.25m
  • Volume: 3,276,128
  • Market Cap: £30.46m
  • RiskGrade: 796
  • Beta: 0.02

Concepta successfully launches 'myLotus' in the UK

By Josh White

Date: Monday 17 Dec 2018

LONDON (ShareCast) - (Sharecast News) - Healthcare company Concepta told the market of the successful launch in the UK of its 'myLotus' product for women's fertility on Monday.
The AIM-traded firm explained that myLotus allowed women to self-test to identify their optimal fertile days, thereby improving their chances of naturally getting pregnant.

It said myLotus enabled women to monitor their fertile phase as part of their menstrual cycle, and was the only home test to 'quantitatively' measure personalised hormone levels and the 'rate-of-change' of those levels preceding ovulation, to help aid a natural conception.

Users measured, recorded and tracked their hormone levels, and followed their fertility journey in an accompanying free downloadable app.

Concepta said that while awareness, profile and sales of the myLotus device were commencing, feedback from early users and fertility bloggers had still been "very positive".

Discussions had also commenced with what the company described as 'key opinion leaders' to advise on the wider use of myLotus, especially for women who wished to monitor their hormonal levels, and for those who had previously struggled to conceive naturally, enabling an alternative for couples prior to considering more costly in vitro fertilisation (IVF) treatment.

In addition to the growing myLotus digital UK presence, the company said it was preparing plans for the roll-out of myLotus across Europe under its CE-mark approval.

Commercial discussions had also begun with retail providers, to make myLotus more broadly available across the UK.

"Although marketing and communications around myLotus® are just beginning, feedback from the early users has been exceptional," said Concepta chairman Matthew Walls.

"We will be raising awareness of the value of the myLotus device and its window on fertility over the coming months via an increased online presence, key opinion leaders and marketing of our initial fertility case studies."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

MyHealthchecked Market Data

Currency UK Pounds
Share Price 4.20p
Change Today -0.25p
% Change -5.62 %
52 Week High 6.70
52 Week Low 0.80
Volume 3,276,128
Shares Issued 725.25m
Market Cap £30.46m
Beta 0.02
RiskGrade 796

MyHealthchecked Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
83.01% above the market average83.01% above the market average83.01% above the market average83.01% above the market average83.01% above the market average
69.23% above the sector average69.23% above the sector average69.23% above the sector average69.23% above the sector average69.23% above the sector average
Income Not Available
Growth
21.14% below the market average21.14% below the market average21.14% below the market average21.14% below the market average21.14% below the market average
22.58% below the sector average22.58% below the sector average22.58% below the sector average22.58% below the sector average22.58% below the sector average

MyHealthchecked Dividends

No dividends found

Trades for 14-May-2021

Time Volume / Share Price
16:35 17,500 @ 4.20p
16:29 9,768 @ 4.29p
16:26 8,062 @ 4.15p
16:25 11,376 @ 4.29p
15:24 186,520 @ 4.20p

MyHealthchecked Key Personnel

CEO Penelope McCormick

Top of Page